These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24703854)

  • 1. Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantation.
    Mariño Z; Mensa L; Crespo G; Miquel R; Bruguera M; Pérez-Del-Pulgar S; Bosch J; Forns X; Navasa M
    J Hepatol; 2014 Aug; 61(2):270-7. PubMed ID: 24703854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation.
    Calvaruso V; Dhillon AP; Tsochatzis E; Manousou P; Grillo F; Germani G; Patch D; O'Beirne J; Burroughs AK
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1227-32. PubMed ID: 22432427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation.
    Carrión JA; Torres F; Crespo G; Miquel R; García-Valdecasas JC; Navasa M; Forns X
    Hepatology; 2010 Jan; 51(1):23-34. PubMed ID: 19839063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation.
    Blasco A; Forns X; Carrión JA; García-Pagán JC; Gilabert R; Rimola A; Miquel R; Bruguera M; García-Valdecasas JC; Bosch J; Navasa M
    Hepatology; 2006 Mar; 43(3):492-9. PubMed ID: 16496308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
    Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
    Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.
    Carrión JA; Navasa M; Bosch J; Bruguera M; Gilabert R; Forns X
    Liver Transpl; 2006 Dec; 12(12):1791-8. PubMed ID: 16823833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
    Carrión JA; Fernández-Varo G; Bruguera M; García-Pagán JC; García-Valdecasas JC; Pérez-Del-Pulgar S; Forns X; Jiménez W; Navasa M
    Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis.
    Isgro G; Calvaruso V; Andreana L; Luong TV; Garcovich M; Manousou P; Alibrandi A; Maimone S; Marelli L; Davies N; Patch D; Dhillon AP; Burroughs AK
    J Gastroenterol; 2013 Aug; 48(8):921-9. PubMed ID: 23124603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence.
    Ghabril M; Dickson RC; Krishna M; Machicao V; Aranda-Michel J; Bonatti H; Nguyen JH
    Liver Transpl; 2011 Jun; 17(6):685-94. PubMed ID: 21618689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation.
    Manousou P; Burroughs AK; Tsochatzis E; Isgro G; Hall A; Green A; Calvaruso V; Ma GL; Gale J; Burgess G; O'Beirne J; Patch D; Thorburn D; Leandro G; Dhillon AP
    J Hepatol; 2013 May; 58(5):962-8. PubMed ID: 23262247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantation.
    Guillaud O; Gurram KC; Puglia M; Lilly L; Adeyi O; Renner EL; Selzner N
    Transplant Proc; 2013; 45(6):2331-6. PubMed ID: 23953545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
    Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.
    Poujol-Robert A; Boëlle PY; Conti F; Durand F; Duvoux C; Wendum D; Paradis V; Mackiewicz V; Chazouillères O; Corpechot C; Poupon R
    Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):570-6. PubMed ID: 25130796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
    Berres ML; Trautwein C; Schmeding M; Eurich D; Tacke F; Bahra M; Neuhaus P; Neumann UP; Wasmuth HE
    Hepatology; 2011 Feb; 53(2):596-603. PubMed ID: 21274880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.
    do O NT; Eurich D; Schmitz P; Schmeding M; Heidenhain C; Bahra M; Trautwein C; Neuhaus P; Neumann UP; Wasmuth HE
    Liver Transpl; 2012 Mar; 18(3):298-304. PubMed ID: 22139994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
    Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ
    Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index.
    Benlloch S; Berenguer M; Prieto M; Rayón JM; Aguilera V; Berenguer J
    Liver Transpl; 2005 Apr; 11(4):456-62. PubMed ID: 15776403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus-infected liver transplant recipients.
    Benlloch S; Heredia L; Barquero C; Rayón JM; Pina R; Aguilera V; Prieto M; Berenguer M
    Liver Transpl; 2009 Dec; 15(12):1798-807. PubMed ID: 19938146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Gonzalez-Koch A; Maor-Kendler Y; Batts K; Moreno-Luna L; Poterucha J; Burgart L; Wiesner R; Kremers W; Rosen C; Charlton MR
    Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
    Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
    J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.